MDGL Delta Exposure (DEX)

Net delta exposure for Madrigal Pharmaceuticals Inc (MDGL) options was -$1.39M per 1% move at the Nov 4, 2026 close. It has been positive on 18 of the last 20 trading days. Four weeks earlier, on Oct 7, 2026, it was $97.28M.

Upgrade to unlock Call Wall, Put Wall, and multiple expiration dates.

Upgrade now

Delta Exposure by Strike

Showing results for MDGL, 2026-11-20(m), calls & puts

       

Delta Exposure Stats

Showing results for MDGL, 2026-11-20(m), calls & puts



Net Delta Exposure by Expiration

Showing results for MDGL, 2026-11-20(m), calls & puts. View all expiries

       
Expiration Net DEX Call DEX Put DEX Call Wall Put Wall

MDGL Delta Exposure FAQ

What is delta exposure (DEX)?

Delta exposure estimates the dollar value of shares option dealers hold or owe as a hedge, per 1% move in the underlying.

Is MDGL delta exposure positive or negative?

Madrigal Pharmaceuticals net delta exposure was negative on Nov 4, 2026, at -$1.39M. It has been positive on 18 of the last 20 trading days.

How has MDGL delta exposure changed recently?

Madrigal Pharmaceuticals net delta exposure went from $97.28M on Oct 7, 2026 to -$1.39M on Nov 4, 2026. See the MDGL delta exposure history for a longer view.

What is Madrigal Pharmaceuticals Inc?

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver...

Give feedback on this chart